Influence of Antioxidant SkQ1 on Accumulation of Mitochondrial DNA Deletions in the Hippocampus of Senescence-Accelerated OXYS Rats
- PMID: 26071779
- DOI: 10.1134/S0006297915050120
Influence of Antioxidant SkQ1 on Accumulation of Mitochondrial DNA Deletions in the Hippocampus of Senescence-Accelerated OXYS Rats
Abstract
Reduction of efficiency of oxidative phosphorylation associated with aging and the development of neurodegenerative diseases including Alzheimer's disease is thought to be linked to the accumulation of deletions in mitochondrial DNA (ΔmtDNA), which are seen as a marker of oxidative damage. Recently, we have shown that mitochondria-targeted antioxidant SkQ1 (10-(6'-plastoquinonyl)decyltriphenylphosphonium) can slow the development of signs of Alzheimer's disease in senescence-accelerated OXYS rats. The purpose of this study was to explore the relationship between the development of neurodegenerative changes in the brain of OXYS rats and changes in the amount of mtDNA and the 4834-bp mitochondrial DNA deletion (ΔmtDNA4834) as well as the effect of SkQ1. We studied the relative amount of mtDNA and ΔmtDNA4834 in the hippocampus of OXYS and Wistar (control) rats at ages of 1, 2, 6, 10, and 20 days and 3, 6, and 24 months. During the period crucial for manifestation of the signs of accelerated aging of OXYS rats (from 1.5 to 3 months of age), we evaluated the effects of administration of SkQ1 (250 nmol/kg) and vitamin E (670 mmol/kg, reference treatment) on the amount of mtDNA and ΔmtDNA4834 and on the formation of the behavioral feature of accelerated senescence in OXYS rats - passive type of behavior in the open field test. In OXYS rats, the level of ΔmtDNA4834 in the hippocampus is increased compared to the Wistar rats, especially at the stage of completion of brain development in the postnatal period. This level remains elevated not only at the stages preceding the manifestation of the signs of accelerated brain aging and the development of pathological changes linked to Alzheimer's disease, but also during their progression. However, at age of 24 months, there were no detectable differences between the two strains. SkQ1 treatment reduced the level of ΔmtDNA4834 in the hippocampus of Wistar and OXYS rats and slowed the formation of passive behavior in OXYS rats. These results support the possible use of SkQ1 for prophylaxis of brain aging.
Similar articles
-
Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1.J Alzheimers Dis. 2014;38(3):681-94. doi: 10.3233/JAD-131034. J Alzheimers Dis. 2014. PMID: 24047616
-
Behavioral effects induced by mitochondria-targeted antioxidant SkQ1 in Wistar and senescence-accelerated OXYS rats.J Alzheimers Dis. 2010;21(2):479-91. doi: 10.3233/JAD-2010-091675. J Alzheimers Dis. 2010. PMID: 20555140
-
Antioxidant SkQ1 Alleviates Signs of Alzheimer's Disease-like Pathology in Old OXYS Rats by Reversing Mitochondrial Deterioration.Curr Alzheimer Res. 2017;14(12):1283-1292. doi: 10.2174/1567205014666170621111033. Curr Alzheimer Res. 2017. PMID: 28637402
-
SkQ1 as a Tool for Controlling Accelerated Senescence Program: Experiments with OXYS Rats.Biochemistry (Mosc). 2022 Dec;87(12):1552-1562. doi: 10.1134/S0006297922120124. Biochemistry (Mosc). 2022. PMID: 36717446 Review.
-
An attempt to prevent senescence: a mitochondrial approach.Biochim Biophys Acta. 2009 May;1787(5):437-61. doi: 10.1016/j.bbabio.2008.12.008. Epub 2008 Dec 29. Biochim Biophys Acta. 2009. PMID: 19159610 Review.
Cited by
-
Disentangling Mitochondria in Alzheimer's Disease.Int J Mol Sci. 2021 Oct 26;22(21):11520. doi: 10.3390/ijms222111520. Int J Mol Sci. 2021. PMID: 34768950 Free PMC article. Review.
-
The Rat Brain Transcriptome: From Infancy to Aging and Sporadic Alzheimer's Disease-like Pathology.Int J Mol Sci. 2023 Jan 11;24(2):1462. doi: 10.3390/ijms24021462. Int J Mol Sci. 2023. PMID: 36674977 Free PMC article.
-
Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update.Front Pharmacol. 2019 Aug 23;10:902. doi: 10.3389/fphar.2019.00902. eCollection 2019. Front Pharmacol. 2019. PMID: 31507410 Free PMC article. Review.
-
Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study.Oxid Med Cell Longev. 2019 Jul 15;2019:3984906. doi: 10.1155/2019/3984906. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31396299 Free PMC article.
-
The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence.Antioxidants (Basel). 2022 Jun 22;11(7):1224. doi: 10.3390/antiox11071224. Antioxidants (Basel). 2022. PMID: 35883714 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical